Thomas D'Alonzo, Director at SALIX PHARMACEUTICALS LTD (SLXP), sold 11,530 shares at $110.22 ($1.3M) on 2014-04-22, disclosed to the SEC on 2014-04-24.
Scheduled sale ($1.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.22 | 6,430 | $709K | 55.4% |
| 2 | $111.30 | 3,300 | $367K | 28.7% |
| 3 | $112.54 | 1,800 | $203K | 15.8% |
| Total | $110.89 avg | 11,530 | $1.3M | 100% |
| Filing → |
| SLXP | SELL | 2012-06-12 | $493K | — | Filing → |
| SLXP | SELL | 2011-12-08 | $209K | — | Filing → |
| SLXP | BUY | 2011-08-11 | $21K | — | Filing → |